Search | Page 9 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Improving the diagnosis and treatment of patients with myelodysplastic syndromes through a performance improvement initiative

    ... Challenges exist in the diagnosis and treatment of myelodysplastic syndromes (MDS). Early clinical presentation can be subtle, accurate ...

    Research Article last updated 02/08/2013 - 7:53am.

  2. Which Patients Should Undergo Allogeneic Stem Cell Transplantation for Myelodysplastic Syndromes, and When Should We Do It?

    ... (SCT) can cure a proportion of patients with myelodysplastic syndromes (MDS). However, treatment related toxicities, graft versus host ...

    Research Article last updated 09/29/2015 - 2:40pm.

  3. Methylation of Promoters of microRNAs and their Host Genes in Myelodysplastic Syndromes.

    ... ABSTRACT Myelodysplastic syndromes (MDS) are a group of hematopoietic malignancies characterized by ...

    Research Article last updated 05/14/2013 - 2:58pm.

  4. Specific Plasma Autoantibody Reactivity in Myelodysplastic Syndromes

    ... Increased autoantibody reactivity in plasma from Myelodysplastic Syndromes (MDS) patients may provide novel disease signatures, and possible ...

    Research Article last updated 11/26/2013 - 12:27pm.

  5. Prognostic value of self-reported fatigue on overall survival in patients with myelodysplastic syndromes: a multicentre, prospective, observational, cohort study

    ... BACKGROUND: The clinical presentation of myelodysplastic syndromes is highly variable and so accurate prediction of outcomes in ...

    Research Article last updated 11/10/2015 - 10:47am.

  6. The Incidence and Health Care Resource Burden of the Myelodysplastic Syndromes in Patients in Whom First-Line Hypomethylating Agents Fail

    ... are effective and approved therapies for patients with myelodysplastic syndromes (MDS), many patients do not benefit from treatment, and nearly ...

    Research Article last updated 03/22/2017 - 9:28am.

  7. The value of survival gains in myelodysplastic syndromes.

    ... to the introduction of 3 novel therapies for myelodysplastic syndromes (MDS). STUDY DESIGN: Retrospective study of patients ...

    Research Article last updated 02/21/2017 - 11:36am.

  8. Myelodysplastic syndromes, version 2.2015

    ... The NCCN Guidelines for Myelodysplastic Syndromes (MDS) comprise a heterogeneous group of myeloid disorders with a ...

    Research Article last updated 04/08/2015 - 2:15pm.

  9. Myelodysplastic syndromes

    ... The myelodysplastic syndromes (MDS) represent a heterogeneous group of clonal hematopoietic ...

    Research Article last updated 08/06/2013 - 12:31pm.

  10. The myelodysplastic syndromes flow cytometric score: a 3-parameter prognostic flow cytometric scoring system

    ... The prognosis of myelodysplastic syndromes (MDS) is currently estimated by using the revised ...

    Research Article last updated 12/08/2015 - 1:08pm.